135 related articles for article (PubMed ID: 8912385)
1. Some characteristics of tumour control probability for heterogeneous tumours.
Ebert MA; Hoban PW
Phys Med Biol; 1996 Oct; 41(10):2125-33. PubMed ID: 8912385
[TBL] [Abstract][Full Text] [Related]
2. Optimization of tumour control probability for heterogeneous tumours in fractionated radiotherapy treatment protocols.
Levin-Plotnik D; Hamilton RJ
Phys Med Biol; 2004 Feb; 49(3):407-24. PubMed ID: 15012010
[TBL] [Abstract][Full Text] [Related]
3. On differences in radiosensitivity estimation: TCP experiments versus survival curves. A theoretical study.
Stavrev P; Stavreva N; Ruggieri R; Nahum A
Phys Med Biol; 2015 Aug; 60(15):N293-9. PubMed ID: 26215150
[TBL] [Abstract][Full Text] [Related]
4. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density.
Webb S; Nahum AE
Phys Med Biol; 1993 Jun; 38(6):653-66. PubMed ID: 8346278
[TBL] [Abstract][Full Text] [Related]
5. The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability.
Mackay RI; Hendry JH
Radiother Oncol; 1999 Jan; 50(1):67-75. PubMed ID: 10225559
[TBL] [Abstract][Full Text] [Related]
6. A mathematical approach to optimizing the radiation dose distribution in heterogeneous tumours.
Stavreva NA; Stavrev PV; Round WH
Acta Oncol; 1996; 35(6):727-32. PubMed ID: 8938221
[TBL] [Abstract][Full Text] [Related]
7. Predicting the radiation control probability of heterogeneous tumour ensembles: data analysis and parameter estimation using a closed-form expression.
Fenwick JD
Phys Med Biol; 1998 Aug; 43(8):2159-78. PubMed ID: 9725596
[TBL] [Abstract][Full Text] [Related]
8. Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study.
Søvik A; Malinen E; Bruland ØS; Bentzen SM; Olsen DR
Phys Med Biol; 2007 Jan; 52(2):499-513. PubMed ID: 17202629
[TBL] [Abstract][Full Text] [Related]
9. Optimum parameters in a model for tumour control probability, including interpatient heterogeneity: evaluation of the log-normal distribution.
Keall PJ; Webb S
Phys Med Biol; 2007 Jan; 52(1):291-302. PubMed ID: 17183142
[TBL] [Abstract][Full Text] [Related]
10. The influence of dose heterogeneity on tumour control probability in fractionated radiation therapy.
Wiklund K; Toma-Dasu I; Lind BK
Phys Med Biol; 2011 Dec; 56(23):7585-600. PubMed ID: 22086189
[TBL] [Abstract][Full Text] [Related]
11. The effects of radiotherapy treatment uncertainties on the delivered dose distribution and tumour control probability.
Booth JT; Zavgorodni SF
Australas Phys Eng Sci Med; 2001 Jun; 24(2):71-8. PubMed ID: 11560173
[TBL] [Abstract][Full Text] [Related]
12. Adapting radiotherapy to hypoxic tumours.
Malinen E; Søvik A; Hristov D; Bruland ØS; Olsen DR
Phys Med Biol; 2006 Oct; 51(19):4903-21. PubMed ID: 16985278
[TBL] [Abstract][Full Text] [Related]
13. A TCP model incorporating setup uncertainty and tumor cell density variation in microscopic extension to guide treatment planning.
Jin JY; Kong FM; Liu D; Ren L; Li H; Zhong H; Movsas B; Chetty IJ
Med Phys; 2011 Jan; 38(1):439-48. PubMed ID: 21361212
[TBL] [Abstract][Full Text] [Related]
14. A new method for optimum dose distribution determination taking tumour mobility into account.
Stavrev PV; Stavreva NA; Round WH
Phys Med Biol; 1996 Sep; 41(9):1679-89. PubMed ID: 8884905
[TBL] [Abstract][Full Text] [Related]
15. Microdosimetry and radiocurability: modelling targeted therapy with beta-emitters.
Nahum AE
Phys Med Biol; 1996 Oct; 41(10):1957-72. PubMed ID: 8912374
[TBL] [Abstract][Full Text] [Related]
16. Impact of microscopic disease extension, extra-CTV tumour islets, incidental dose and dose conformity on tumour control probability.
Selvaraj J; Baker C; Nahum A
Australas Phys Eng Sci Med; 2016 Jun; 39(2):493-500. PubMed ID: 27168065
[TBL] [Abstract][Full Text] [Related]
17. Tumour volume distribution can yield information on tumour growth and tumour control.
Schneider U; Besserer J
Z Med Phys; 2022 May; 32(2):143-148. PubMed ID: 34119384
[TBL] [Abstract][Full Text] [Related]
18. The use of a mixed Poisson model for tumour control probability computation in non homogeneous irradiations.
Cutanda Henríquez F; Vargas Castrillón S
Australas Phys Eng Sci Med; 2011 Jun; 34(2):267-72. PubMed ID: 21512837
[TBL] [Abstract][Full Text] [Related]
19. Potential implications of the bystander effect on TCP and EUD when considering target volume dose heterogeneity.
Balderson MJ; Kirkby C
Int J Radiat Biol; 2015 Jan; 91(1):54-61. PubMed ID: 25004946
[TBL] [Abstract][Full Text] [Related]
20. Modelling the effect of spread in radiosensitivity parameters and repopulation rate on the probability of tumour control.
Stavreva N; Stavrev P; Balabanova A; Nahum A; Ruggieri R; Pressyanov D
Phys Med; 2019 Jul; 63():79-86. PubMed ID: 31221413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]